BRIEF-Cleveland-Cliffs Says Ready To Acquire Any Union-Represented Assets U.S. Steel Shuts Down-March 2024-www.financetom.com

BRIEF-Cleveland-Cliffs Says Ready To Acquire Any Union-Represented Assets U.S. Steel Shuts Down

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Cleveland-Cliffs Says Ready To Acquire Any Union-Represented Assets U.S. Steel Shuts Down

Sep 6, 2024 1:19 PM

Sept 5 (Reuters) - Cleveland-Cliffs Inc ( CLF ):

* CLEVELAND-CLIFFS COMMENDS PRESIDENT BIDEN'S REPORTED

DECISION TO

BLOCK FOREIGN OWNERSHIP OF U.S. STEEL BY JAPAN'S NIPPON STEEL

* CLEVELAND-CLIFFS INC ( CLF ) - STANDS READY TO IMMEDIATELY

ACQUIRE AND

INVEST IN ANY AND ALL UNION-REPRESENTED ASSETS THAT U.S. STEEL

SHUTS DOWN

Source text for Eikon:

Further company coverage:

Previous page： Evolus Completes FDA Premarket Approval Submission for Evolysse Dermal Fillers for 'Smile Lines' Next page： Altimmune Stock Is Rising Monday: What's Driving The Action?

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Evolus Completes FDA Premarket Approval Submission for Evolysse Dermal Fillers for 'Smile Lines'

Jun 24, 2024

09:03 AM EDT, 06/24/2024 (MT Newswires) -- Evolus ( EOLS ) said Monday it submitted the final part of its premarket approval application to the US Food and Drug Administration for its Evolysse dermal filler products for nasolabial folds, also known as smile lines. The application covers Evolysse Lift and its softer alternative Evolysse Smooth, Evolus ( EOLS ) said,...

Altimmune Stock Is Rising Monday: What's Driving The Action?

Jun 24, 2024

Altimmune Inc ( ALT ) shares are trading higher Monday after the company announced data from the 48-week Phase 2 MOMENTUM clinical trial of pemvidutide. What Happened: Altimmune ( ALT ) said it presented data from the 48-week Phase 2 MOMENTUM clinical trial of pemvidutide, including the results of a recently completed body composition analysis at the American Diabetes Association’s...

Fangdd Network to Acquire Cloud Computing Patents for $35 Million

Jun 24, 2024

09:13 AM EDT, 06/24/2024 (MT Newswires) -- Fangdd Network Group ( DUO ) said Monday it has agreed to acquire $35 million in cloud computing patents that expand its existing customer-oriented real estate technology business to property management. In addition to the initial payout, the patent seller will be entitled to up to $15 million in royalty payments in 2024,...

Eos Energy Receives $315.5 Million Investment From Cerberus

Jun 24, 2024

09:15 AM EDT, 06/24/2024 (MT Newswires) -- Eos Energy Enterprises ( EOSE ) said Monday that an affiliate of Cerberus Capital has invested up to $315.5 million to enable Eos Energy ( EOSE ) to restructure existing debt and expand operations. The investment is structured as a $210.5 million delayed draw term loan contingent on operational milestones through April 2025...